Gujarat Terce Laboratories Ltd. reported unaudited earnings results for third quarter and nine months ended December 31, 2012. For the quarter, the company reported net sales (net of exercise duty) of INR 103.9 million against INR 264.9 million for same period a year ago. Profit from operations before other income, finance costs and exceptional items were INR 2 million against INR 1.2 million for same period a year ago. Net profit was INR 1.2 million or INR 0.17 per diluted share before and after extraordinary items against INR 0.2 million or INR 0.02 per diluted share before and after extraordinary items for same period a year ago. Profit from ordinary activities before tax was INR 1.2 million against INR 0.2 million a year ago.
 
For the nine months, the company reported net sales (net of exercise duty) of INR 830.1 million against INR 925.4 million for same period a year ago. Profit from operations before other income, finance costs and exceptional items were INR 4.4 million against INR 5.2 million for same period a year ago. Net profit was INR 1.4 million or INR 0.19 per diluted share before and after extraordinary items against INR 1.8 million or INR 0.25 per diluted share before and after extraordinary items for same period a year ago. Profit from ordinary activities before tax was INR 1.4 million against INR 2 million a year ago.